Drive your career as you manage critical account relationships, execute dynamic business strategies, and deliver impactful education for Infigratinib—an innovative treatment for achondroplasia—while supporting families and healthcare providers.

Lead the charge in transforming healthcare as you manage territory business plans, engage healthcare providers, and drive the launch of innovative therapies for skeletal dysplasia, fostering partnerships with families for impactful outcomes.

Transform your career by driving the launch of a groundbreaking therapy for achondroplasia. Collaborate with healthcare providers and families in a high-impact role that champions care in the skeletal dysplasia community and builds lasting relationships.

Drive commercial success by developing territory plans for geneticists and specialists, launching Infigratinib for achondroplasia, and building strong partnerships with healthcare providers and families in the skeletal dysplasia community.

Champion the launch of Infigratinib, collaborating with providers to drive excellence in care for families affected by skeletal dysplasia. Utilize deep clinical expertise to exceed sales goals across diverse healthcare settings.